Medical Science Liaison (Central Italy) - Award winning, global mid-sized pharmaceutical company - Competitive salary + benefits package
Seeking a skilled
MSL
to cover
Central Italy
, preferably based in Rome. You will cover the operational area of Marche, Umbria and Lazio. This role involves engaging with key opinion leaders (KOLs) and contributing to advancements in
infectious diseases
specialty care
.
Key Responsibilities: Develop and maintain a comprehensive list of healthcare professionals (HCPs) and key external experts (KEEs), ensuring effective territory coverage and engagement planning. Share emerging on-label data and disease-related information with HCPs in a scientific, objective, and balanced manner. Collaborate with KEEs/HCPs in scientific initiatives to enhance disease understanding, including speaker identification and preparation, clinical trials, and investigator-initiated trials (IITs). Provide non-promotional scientific support to various activities such as hospital formulary listings, payer engagements, and speaker training sessions. Respond to unsolicited medical inquiries in an accurate and timely manner. Gather insights from scientific interactions with HCPs to inform internal stakeholders about clinical practice trends and knowledge gaps. Deliver therapeutic area and product training to internal teams where applicable. Stay updated on the latest scientific knowledge and industry developments through ongoing training and professional development.
Key Qualifications & Skills: Degree in life sciences, medicine or pharmacy Fluency in Italian
and a high level of proficiency in written and spoken
English 3+ years’
experience as an MSL Desired experience in
infectious diseases, intensive care or haemato-oncology. Comprehensive understanding of the pharmaceutical industry, prescription processes, and drug distribution in Italy. Ability to work cross-functionally and build strong professional relationships.
If this opportunity interests you, please submit your CV to megan@warmanobrien.com to apply now. This organisation is looking to welcome the new MSL onboard ASAP.